Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
SyntheMed logo — Innovative surgical implants crafted to minimize post-operat...

SyntheMed

Innovative surgical implants crafted to minimize post-operative adhesions and enhance healing.

Founded 1990 Biotechnology, Hardware

General Information

Company Name SyntheMed
Founded Year 1990
Industries Biotechnology, Hardware
Social

Get notified when SyntheMed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SyntheMed

SyntheMed is a biomaterials company established in 1990 that specializes in pioneering medical devices aimed at therapeutic use. Leveraging its innovative bioresorbable polymer technology, the company's flagship products primarily comprise surgical implants, strategically designed to prevent or minimize the formation of adhesions (scar tissue) post various surgical procedures. Notably, one of its key offerings, the REPEL-CV Bioresorbable Adhesion Barrier (REPEL-CV), stands out as a bioresorbable film specifically tailored for application on the heart's surface post cardiac surgery, with the objective of minimizing post-operative adhesions. In a significant development, the company secured FDA clearance for selling REPEL-CV in the United States in March 2009. With a focus on the biotechnology and hardware industries, SyntheMed integrates cutting-edge technology into its products, positioning itself as a noteworthy player in the realm of innovative surgical implants.

Taxonomy: biomaterials, bioreasorbable polymer technology, surgical implants, therapeutic use, adhesion prevention, FDA clearance, cardiac surgery, bioresorbable film, post-operative healing, innovative implants, surgical procedures

No funding data available for SyntheMed yet.

Get notified when SyntheMed raises funding

SyntheMed Alternatives & Competitors

SyntheMed vs
Osteopore (OSX.AX)
Osteopore (OSX.AX) Singapore

Global leader in regenerative solutions | The trusted bioresorbable implant that enables confident l...

22 employees
3D Printing
SyntheMed vs
Sporogenics Pte Ltd
Sporogenics Pte Ltd Singapore

Degradable biopolymer barriers for postoperative anti-adhesion solution.

1 employees
Health Care, Medical Devices
SyntheMed vs
Pioneer Surgical Orthobiologics Inc.
Pioneer Surgical Orthobiologics Inc.

Empowering surgeons with advanced biologic, metal, and synthetic implants since 1992.

Series Unknown
1 employees
Biotechnology, Health Care

FAQ About SyntheMed

Innovative surgical implants crafted to minimize post-operative adhesions and enhance healing.
SyntheMed was founded in 1990.
SyntheMed operates in the following industries: Biotechnology, Hardware.
Top alternatives and competitors to SyntheMed include Osteopore (OSX.AX), Sporogenics Pte Ltd, Pioneer Surgical Orthobiologics Inc., HNM Medical, Sonavex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SyntheMed and Osteopore (OSX.AX) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SyntheMed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy